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ABSTRACT
Introduction: Cannabis use and dependence is a
serious health and criminal justice issue among
incarcerated populations internationally. Upon abrupt,
enforced cessation of cannabis, prisoners may suffer
irritability and anger that can lead to threatening
behaviour, intimidation, violence, sleep disturbances and
self-harm. Cannabis withdrawal syndrome, proposed for
inclusion in the Diagnostic and Statistical Manual of
Mental Disorders in 2013, has not been examined in
Indigenous populations. Owing to the exceptionally high
rates of cannabis use in the community, high proportions
of Australian Indigenous prisoners may suffer from
withdrawal upon entry to custody.
Methods and analysis: 60 male and 60 female
Indigenous prisoners (18–40 years) at a high risk of
cannabis dependence will be recruited upon entry to
custody. A pictorial representation of the standard
Cannabis Withdrawal Scale will be tested for reliability and
validity. Cortisol markers will be measured in saliva, as the
indicators of onset and severity of cannabis withdrawal
and psychological distress. The characteristics will be
described as percentages and mean or median values
with 95% CI. Receiver operator curve analysis will
determine an ideal cut-off of the Cannabis Withdrawal
Scale and generalised estimating equations modelling will
test changes over time. The acceptability and efficacy of
proposed resources will be assessed qualitatively using
thematic analysis.
Outcomes: A valid and reliable measure of cannabis
withdrawal for use with Indigenous populations, the onset
and time course of withdrawal symptoms in this
population and the development of culturally acceptable
resources and interventions to identify and manage
cannabis withdrawal.
Ethics and dissemination: The project has been
approved by the James Cook University Human Research
Ethics Committee (approval number H4651).The results
will be reported via peer reviewed publications,
conference, seminar presentations and on-line media for
national and international dissemination.
INTRODUCTION
Cannabis withdrawal is recognised as a conse-
quence of cannabis dependence following
the cessation of use.1 The symptoms include
irritability, anger or aggression; nervousness
or anxiety; insomnia; decreased appetite or
weight loss; restlessness; depressed mood;
and physical symptoms, for example,
ARTICLE SUMMARY
Article focus
▪ The experience of cannabis withdrawal has not
been the focus of any studies in Indigenous
populations.
▪ This study aims to produce a valid and reliable
measure of cannabis withdrawal for use with
Indigenous populations and document the onset
and time course of withdrawal symptoms.
▪ Studies with the potential for therapeutic
outcome comprise a small proportion of pub-
lished prisoner research.
Key messages
▪ A better understanding of cannabis withdrawal in
custodial settings could assist in better risk man-
agement processes.
▪ Resources developed will assist new prison
inmates to manage cannabis withdrawal and may
assist communities to manage ‘stressing out’,
widely observed and reported when cannabis is
not available.
Strengths and limitations of this study
▪ There is a dearth of research pertaining to can-
nabis withdrawal in Indigenous populations, who
are at a risk of cannabis-related harms owing to
endemic levels of use with associated mental
health issues.
▪ Custodial settings provide a controlled environ-
ment that addresses many of the methodological
issues of previous studies.
▪ The main limitations of this study related to
exploring illicit drug use is a stigmatised and
sensitive topic, the study must fit within the tight
schedules of a corrections environment and con-
founding variables such as stress owing to incar-
ceration, withdrawal from tobacco and other
substance use and pre-existing or undiagnosed
mental health issues may impact the results.
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headache and sweating. Symptoms typically begin within
24 h of cessation, persisting for up to 28 days.2 3
Cannabis withdrawal syndrome is proposed for inclu-
sion in the next Diagnostic and Statistical Manual of
Mental Disorders, fifth edition (DSM-5).4 Of particular
clinical importance, withdrawal contributes to difficulties
abstaining from cannabis5 and increases the likelihood
of relapse in order to relieve withdrawal distress.6 7 The
proposed DSM-5 cannabis withdrawal syndrome criteria
are informed by studies conducted mainly in treatment-
seeking groups and adolescents,1 in whom higher rates
of use and cannabis-related problems have been
documented.2 4 5 No known published studies have spe-
cifically targeted ethnic minorities or marginalised sub-
populations such as the First Nations and Indigenous
peoples of North America or Australasia.
This study focuses on Indigenous Australians in one part
of northern Australia, where the levels of cannabis use are
very high. While cannabis use in Australia’s general popula-
tion may have been declining,8 the impacts of endemic
cannabis use in remote Indigenous Australian communi-
ties are increasingly evident.9 Australian government
surveys report past-year cannabis use for Indigenous
Australians of 16% compared to 10% of the general popu-
lation.8 Studies in remote communities in Australia’s
Arnhem Land, Northern Territory10 and Cape York, far
north Queensland,11 have documented very high rates, up
to 66% (in those aged 13–36 years), with a reported rapid
rise in cannabis use in the late 1990s.10
Cannabis use is associated with criminal behaviours
and incarceration.12 Unpublished pilot data were col-
lected from 101 males incarcerated for 2 years or less in
a far north Queensland correctional centre including
69% who were self-reported current cannabis users
before incarceration: 70% recalling three or more symp-
toms of cannabis withdrawal during the week following
their arrest.13 Participants also described ‘stressing out’
characterised by aggression, intimidation and anxious-
ness, contributing to disrupting family/relationships5
when cannabis was not available in their home commu-
nity. ‘Stressing out’ may be a phenomenon similar to, if
not the same as, cannabis withdrawal.
Indigenous Australians are incarcerated 15 times more
frequently than the general population,14 with a rapidly
increasing rate of incarceration for females of great
concern.15 Higher rates of cannabis use are found in
prison inmates and expectation of post-release drug use
is a significant predictor of reincarceration.16 This
project explores the nature and prevalence of the canna-
bis withdrawal syndrome and its measurement among
individuals immediately following incarceration. The
findings will enhance screening in prisons and similar
environments and provide approaches to develop tar-
geted interventions for cannabis withdrawal. The tightly
controlled conditions of enforced abstinence in prison
inmates close to entry into custody furnish a rare oppor-
tunity to understand cannabis withdrawal and the
experience of ‘stressing out’ as well as an opportunity to
address an unmet need for support in this highly mar-
ginalised and disadvantaged group.
The study objectives are to
1. Explore the experience of ‘stressing out’ in Indigenous
Australians, identify culturallyspecific concepts of with-
drawal, and use this information to inform the valid-
ation of a modified Cannabis Withdrawal Scale (I-CWS)
for use with Indigenous Australian prison inmates.
2. Document onset, time course and severity of with-
drawal symptoms in new Indigenous prison inmates
who are dependent cannabis users, and compare this
information with biological cortisol markers, taking
into account recent alcohol and other drug use
before arrest.
3. Using data from #1 and #2, and information from focus
groups with prison inmates and prison staff, devise cul-
turally acceptable, low-cost resources to assist in the
management of cannabis withdrawal in controlled
environments such as prisons and watch houses.
4. Disseminate resources to prison inmates and evaluate
their acceptability and uptake.
METHODS AND ANALYSIS
Study overview
This study design is in line with the first and second
phases in the schema of Campbell et al,17 for the design
and implementation of complex interventions to
improve health: ‘modelling or identifying components
of an intervention which are likely to work’ and an
‘exploratory trial of components’.
While Western views and assessment of mental health
and ill health typically focus on personal experience,
indigenous concepts of mental health are often more
holistic and consider spirituality, environment, family
and community in addition to personal experiences.18
Considering this, symptom assessment methodologies
for cannabis withdrawal will be validated to ensure cul-
tural relevance. Aspects of cultural equivalence will be
explored systematically using both qualitative and quanti-
tative measures.19
To accomplish the first objective, the validated
CWS20 21 will be administered together with a semistruc-
tured interview to explore patterns and experiences of
cannabis use. The themes in the data will assist to better
understand symptoms and how they are experienced by
inmates during initial incarceration when cannabis use
is curtailed. Themes and symptoms will be considered
by an expert reference group and cultural informants to
develop a modified CWS, (I-CWS) for piloting.
For the second objective, new prisoners, within 1 week
of incarceration, will undergo examination for sympto-
mology and severity of cannabis withdrawal using a
battery of scales, including the modified I-CWS mea-
sured on eight occasions over 28 days (figure 1).
The third and fourth objectives involve a series of focus
groups comprised of prison inmates and prison staff.
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Semistructured interviews will be used to develop the
I-CWS (Objective 1); the cannabis withdrawal assess-
ments of new prison inmates (Objective 2) will be used
to refine it during the first 12 months. The resource
development phase (Objective 3) will overlap with inter-
views and assessments. The resource dissemination and
evaluation phases (Objectives 3 and 4) will start by the
18th month and will be completed by the end of the
21st month. The design allows 24 months for interviews,
assessments, focus groups, data analysis, research feed-
back and reporting (figure 2). A process evaluation will
be undertaken over the course of the project.
Setting
Data will be collected using interviews with prisoners in
three custodial localities in north Queensland—a watch
house run by the Queensland Police Service (QPS) and
two correctional centres run by Queensland Department
of Corrections (QCS). North Queensland correctional
centres report that 65–80% of prison inmates identify as
Indigenous Australian, many of whom are from commu-
nities in Cape York and Torres Strait regions in far north
Queensland.
Cape York covers 12 statistical regions, ∼128 000 km2
(7.4% of the total area of Queensland) with a popula-
tion of approximately 7800 Indigenous Australians.22
The Torres Strait Islands is a cluster of over 250
islands ∼1380 km2 (0.1% of the total area of
Queensland) with a population of approximately 5900
Indigenous Australians.23
Specific methodological and ethical considerations
arise in conducting research in a prison or detention
environment.24 Involving prisoners as cultural infor-
mants to guide the recruitment process may assist to
minimise the prospect that prisoners will feel coerced or
that there is undue inducement or obligation to speak
to a researcher. Additional measures must ensure that
recruitment does not lead to any misapprehension of
possible benefit including sentence reduction or help
with parole.25
Participant selection and recruitment
Participant selection will occur in three stages outlined
in figure 3. Firstly, to validate the I-CWS (Objective 1),
participants will be prisoners who have been in custody
for 2–24 months, be 18–40 years, Indigenous (Aboriginal
and/or Torres Strait Islander) and will have tried canna-
bis at least once in the 12 months preceding incarcer-
ation to ensure variance in former levels of use and
dependence. For Objective 2, participants will be new
prisoners, 18–40 years, Indigenous, heavy cannabis users
(five or more days use on an average over the 3 months
before prison), cannabis dependent and available to
complete withdrawal symptom assessments on eight
occasions over 28 days. Initial assessment will start at the
QPS watch house and will be completed while in prison.
To recognise cultural differences between Aboriginal
and Torres Strait Islanders, Objective 3 will be achieved
by inviting prison inmates to join one of two focus (F)
groups—Aboriginal (F1) and Torres Strait Islanders
Figure 2 Timeline to achieve
Objectives 1–4.
Figure 1 Assessments conducted over a 28-day period.
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(F2). A third focus group (F3) will consist of QCS prison
officers with at least 6 months service. Focus groups will
guide the content and parameters of resource develop-
ment to manage withdrawal, which will be disseminated
before evaluating their utility and uptake (Objective 4).
Potential participants will be excluded if there are con-
founding health/mental health issues or if the partici-
pant is deemed unsuitable for interview by QCS staff.
For each objective, the exclusion criteria are
Objectives 1, 3 and 4: those aged <18 and >40 years.
Objective 2: those aged <18 and >40 years, who are
alcohol or other drug dependent (using National Health
and Medical Research Council (NHMRC) guidelines26
and/or DSM dependence criteria and previously under-
gone any drug treatment, detoxification or rehabilitation.
Notices asking for volunteers to participate in the study
will be placed within the correctional centres. To ascer-
tain the eligibility for Objective 2, upon reception to the
police watch house, QPS officers will notify researchers of
those who are identified as Indigenous and who are aged
between 18 and 40 years. Researchers will meet the
detainee to provide an information sheet and explain the
study purpose and design, voluntary participation and
procedures for withdrawing from the study. Written
informed consent will be obtained from those who wish
to participate and a full eligibility assessment undertaken.
Participants will be compensated $5 for each assessment
completed (total $40 if all assessments completed) with
the payment made to their institutional account. Paying
prison inmates for participation is a matter of some con-
troversy, but is common in criminological research.27 The
initial battery of scales will be administered taking
approximately 40 min, with subsequent assessments
requiring between 10 and 30 min (figure 1).
Sample size calculation
Qualitative
A purposive sample of 20 Indigenous prison inmates
and 10 QCS prison officers will be invited to join one of
three focus groups. Qualitative studies usually have
smaller sample sizes of 10–20 deemed suitable to
achieve data saturation.28
Quantitative
Pilot data13 provided estimates of the potential sample
pool with 79% of prisoners being identified as
Indigenous, 69% as cannabis users and 84% who had
experienced one or more withdrawal symptoms before
incarceration. The sample pool will be 314 males (based
on 750 new prison inmates estimated over study period)
and 156 females (with an estimated 330 new prison
inmates over study period).
A sample size of 60 men and 60 women is a practical
and achievable target with the resources available. With
the prevalence of withdrawal symptoms, expected from
pilot data to be approximately 70%, a precision of 0.264
can be achieved (95% CI 0.568 to 0.812). These sample
sizes provide study power in excess of 80% to detect dif-
ferences between the eight repeated measures from
baseline to 28 days (significance of 0.05) enabling a time
series analysis of symptom score to be adjusted for three
characteristics with one degree of freedom and still
maintaining a stable model.29
MEASURES/DATA COLLECTION
Questionnaire adaptation
An interactive and conversational approach, ‘research
yarning’,30 is congruent with local and regional cultural
processes. Questionnaires will be developed with focus
groups and cultural informants using this approach to
ensure appropriate wording/language, placement and cul-
tural context. Qualitative data will be collected during this
adaptation phase to ensure compatibility with cultural
context and, once the questionnaires have been revised, a
test-retest will be undertaken to ensure reliability.
Information collection
A series of open-ended questions will be used in the eli-
gibility assessments to build rapport and to determine
whether inclusion criteria are met. The timeline follow
back method31 will be used at the eligibility interview to
assess each participant’s use of cannabis and other sub-
stances before incarceration, withdrawal symptoms,
impact on family, finances and community, quitting
intentions/attempts, understanding of withdrawal/‘stres-
sing out’ and if any strategies were used to manage
withdrawal.
Both qualitative and quantitative data will be collected
during this phase. Participants will be asked their age,
living arrangements before incarceration, education and
work history.
Figure 3 Participant selection
for Objectives 1–4.
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Quantitative measures
We will assess the participants at baseline and on days 1,
3, 5, 7, 10, 14 and 28 following initial detention
(figure 1). Alcohol, cannabis and other drug use will be
measured using the Alcohol, Smoking and Substance
Involvement Screening Test,32 with cannabis depend-
ence measured at baseline and again at 28 days, using
the Severity of Dependence Scale.33 As not all measures
are validated for use with Indigenous prison inmates,
structured clinical interviews34 will assess dependence,
presence of mood episodes/disorders, psychotic and
anxiety and adjustment disorders along with possible
other drug dependence. To account for and monitor
stresses experienced early in incarceration, psychological
distress will be measured at baseline and subsequently
on seven occasions using the modified Kessler 6
Psychological Distress Scale (K6), which has been used
previously in Indigenous populations.35 Salivary cortisol
levels, a non-intrusive objective marker of stress,36 will be
assessed on the same days as psychological distress using
the K6. The eight I-CWS assessments will be used to val-
idate the CWS (figure 1).
This schedule is feasible within the routine of prison
programming with 960 assessments (60 male and 60
female participants × 8 occasions) to be conducted
overall. At day 28, when withdrawal symptoms are likely
to have subsided,37 a further assessment of dependence
and an in-depth interview will also be conducted to
explore qualitative experiences of withdrawal.
The research will be guided by experts in substance
misuse and treatment including Indigenous cultural
advisors, by cultural officers employed by QCS. Cultural
informant groups, consisting of prison inmates at each
site, will be formed through several group discussions.
All groups will guide the development of the I-CWS to
examine the validity of the symptoms and understanding
of withdrawal and ‘stressing out’. The groups will also
provide input to the format of the I-CWS with regard to
pictorial representation and the phrasing and wording
of the symptom description.
Process measures
Resources aimed at enabling new prison inmates to rec-
ognise and manage symptoms of cannabis withdrawal
will be developed and assessed within an action research
framework, guided by the expert reference group,
Indigenous advisors and cultural informants. These
resources will be piloted with new prison inmates prior
to dissemination for use by prison staff, as far as it is
practicable.38
Because of the national importance of reducing rates
of incarceration in Indigenous people,39 the procedures
used to engage QCS in embedding the resources into
current practice will be described. We will record, via an
implementation log completed by prison staff, the
extent to which these resources are provided to, and
used by, the prison inmate population.
Acceptability and feasibility will be determined by the
administration of an additional questionnaire/interview
at focus group meetings 4, 5 and 6 (figure 2), the
expert reference group, Indigenous advisors and cul-
tural informants.
PROPOSED INTERVENTIONS
Treatments for cannabis withdrawal are only beginning
to be investigated with no evidence-based interventions
available for Indigenous populations. Currently, there is
very little support for the treatment of cannabis-related
problems for Indigenous populations, incarcerated or
not. Managing withdrawal symptoms currently focuses
on information provision and psychosocial interventions
(eg, counselling and sleep management).40 41
The complex relationship between drug use and crim-
inal behaviour, with differences occurring between men
and women, requires any treatment or intervention to
target specific personal drug use and mental health histor-
ies. Factors common to drug use and crime (eg, sexual/
physical abuse, mental health problems, family problems)
should be identified and treated concurrently.42
The focus groups will guide the development of the
interventions and may range from brief interventions to
stepped care models, based on psychosocial or social cog-
nition therapies. Frameworks to be considered include
psychoeducation, motivational enhancement, cognitive
behaviour-based therapies,9 family and social emotional
well-being43 and/or social cognition training.44 It is
intended that interventions will focus on continuing
rehabilitation after release to assist with reintegration and
management to reduce the risk relapse.
Intervention components will be developed in consult-
ation with the focus groups to ensure cultural relevance
and to align with best practice frameworks, so that they
are practical, appropriate for the average level of cogni-
tive function evident among prison inmates and address
the identified needs for treatment.45
ANALYSIS OF DATA
Qualitative analysis
For Objective 1, themes described and symptoms experi-
enced during initial incarceration and when cannabis
use is curtailed will be documented. Using a simplified
Delphi technique, already applied in Indigenous mental
health research,46 themes and symptoms will be consid-
ered by the expert reference group and mapped against
the CWS. Themes and symptoms will be provided to the
expert reference group blinded and conducted in
rounds until consensus is obtained.
To achieve the third and fourth objectives, qualitative
information will be transcribed and analysed by two
researchers. Sampling will continue until data are satu-
rated with no new themes or categories emerging from
the data. NVIVO software enables multilevel coding of
text against a set of predetermined analytical categories.
The research team will use an iterative process to
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understand the themes and key issues arising from the
data, which will be coded independently with divergent
views reconciled by a third researcher.
Statistical analysis and data management
To accomplish Objective 2, generalised estimating equa-
tions will be used to analyse Indigenous I-CWS scores
over time.47 Modelling will test influences of time in
abstinence from cannabis on total daily withdrawal
scores (dependent variable) summed across all valid
items in the Indigenous I-CWS. Demographic and other
characteristics will be examined for their role in influen-
cing scores over time.
Statistical analysis of quantitative data will be per-
formed using IBM PASW SPSS software V.20.0 (IBM
SPSS, Chicago, Illinois, USA) and analysis of qualitative
data supported by QSR NVIVO V.10.
LIMITATIONS
Illicit drug use is a stigmatised and sensitive topic which
may hinder recruitment and retention of participants.
In addition, the study must fit within the tight schedules
and local procedures at the three sites run by QPS and
QCS. The study includes only two prison sites within
Queensland and generalisations must be made with
caution. However, this research is made possible by
sound local relationships of trust with prison inmates
with advice sought from the prison inmate reference
group as cultural informants, enhancing its transferabil-
ity. Protocols within the QPS watch house and QCS cor-
rectional centres will be adhered to at all times. The
limited available resources prevent a larger scale multi-
site study.
There are risks associated with participation in this
research which could implicate participants in further
criminal charges if incriminating information is dis-
closed. Participants will be informed of this risk before
involvement in the study and of the right to withdraw at
any stage. A risk-management strategy24 proposes that
matters of high risk and of intrinsic interest to law
enforcement would be avoided in the study, that is,
supply and distribution networks and participants’ roles
in them, matters related to other crimes not heard
before a court or under investigation and/or matters
related to any future planned crimes.
Confounding variables such as stress related to incar-
ceration, withdrawal from tobacco and other substance
use and pre-existing or undiagnosed mental health
issues may impact the results.
RELEVANCE
There is a dearth of research pertaining to cannabis
withdrawal in Indigenous populations, arguably the most
at-risk populations for cannabis-related harms in
Australia owing to endemic levels of use with associated
mental health issues. Indigenous Australians are four to
five times more likely than non-Indigenous Australians
to be hospitalised for mental or behavioural disorders
owing to the use of psychoactive substance.48 In remote
communities in the Cape York region of far north
Queensland, endemic cannabis has been linked to psych-
osis which is believed to play a role in the onset of illness
in 61% of men and 37% of women (aged ≥15 year).49
Studies with the potential for therapeutic outcome
comprise a small proportion of published prisoner
research.39 In the USA, and mirrored in Australia, pris-
oners released to liberty are returning to their communi-
ties with a plethora of unaddressed health issues,
particularly mental health and substance abuse pro-
blems.50 51 Resources developed will assist new prison
inmates to manage cannabis withdrawal and may assist
communities to manage ‘stressing out’, widely observed
and reported when cannabis is not available.
Of considerable importance, the results of this study
will provide information about the onset, time-course
and severity of withdrawal of populations in a non-
treatment study population, the focus of few cannabis
withdrawal studies. Custodial settings provide a controlled
environment that addresses many of the methodological
issues of previous studies where participant recruitment,
drop out and abstinence has been problematic.
The strength of this research team is its capacity to
translate the practical outcomes of the study to the
development of sustainable, easily delivered resources
to better manage mental health, withdrawal and
cannabis-related issues in newly incarcerated Indigenous
prison inmates.
ETHICS AND DISSEMINATION
The James Cook University ( JCU) Human Research
Ethics Committee has approved the proposal for the
study H4651, as well as related information sheets and
consent forms summarising the research and roles of
potential participants. All project data will be deidenti-
fied by removing the statements identifying participants
prior to their use in published materials. All question-
naire, interview and focus group data will be stored
securely in password-protected folders accessible only to
the research team. In accordance with Australia’s
NHMRC guidelines,52 all project data will be retained
for a minimum of 7 years. Participants will be provided
with contact details of the research team to enable them
to address any potential queries or concerns. Any com-
plaints will be systematically recorded and acted upon in
accordance with JCU guidelines. Participants will be
informed of their right to access their own results,
and the overall results of the research, in accordance
with NHMRC guidelines.51 Journal articles developed
from the research will be sent to all project partners for
dissemination to participants, and deidentified results
provided in progress reports to QCS and QPS.
Conference and seminars will be presented to Australian
and international healthcare stakeholders, researchers
and academics.
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